- Home
- MNPR vs CAN Comparison
MNPR vs CAN Comparison
Compare MNPR & CAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MNPR
- CAN
- Stock Information
- Founded
- MNPR 2014
- CAN 2013
- Country
- MNPR United States
- CAN Singapore
- Employees
- MNPR N/A
- CAN N/A
- Industry
- MNPR Biotechnology: Pharmaceutical Preparations
- CAN Semiconductors
- Sector
- MNPR Health Care
- CAN Technology
- Exchange
- MNPR Nasdaq
- CAN Nasdaq
- Market Cap
- MNPR 390.5M
- CAN 372.5M
- IPO Year
- MNPR 2019
- CAN 2019
- Fundamental
- Price
- MNPR $99.37
- CAN $1.31
- Analyst Decision
- MNPR Strong Buy
- CAN Strong Buy
- Analyst Count
- MNPR 12
- CAN 6
- Target Price
- MNPR $89.82
- CAN $2.50
- AVG Volume (30 Days)
- MNPR 78.9K
- CAN 57.0M
- Earning Date
- MNPR 11-07-2025
- CAN 11-19-2025
- Dividend Yield
- MNPR N/A
- CAN N/A
- EPS Growth
- MNPR N/A
- CAN N/A
- EPS
- MNPR N/A
- CAN N/A
- Revenue
- MNPR N/A
- CAN $345,360,000.00
- Revenue This Year
- MNPR N/A
- CAN $78.37
- Revenue Next Year
- MNPR N/A
- CAN $48.46
- P/E Ratio
- MNPR N/A
- CAN N/A
- Revenue Growth
- MNPR N/A
- CAN 82.40
- 52 Week Low
- MNPR $4.50
- CAN $0.53
- 52 Week High
- MNPR $105.00
- CAN $3.27
- Technical
- Relative Strength Index (RSI)
- MNPR 88.79
- CAN 73.18
- Support Level
- MNPR $72.41
- CAN $0.78
- Resistance Level
- MNPR $105.00
- CAN $1.57
- Average True Range (ATR)
- MNPR 7.21
- CAN 0.13
- MACD
- MNPR 2.86
- CAN 0.06
- Stochastic Oscillator
- MNPR 89.52
- CAN 64.75
About MNPR Monopar Therapeutics Inc.
Monopar Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. The company's pipeline consists of Validive for the prevention of chemoradiotherapy-induced severe oral mucositis in oropharyngeal cancer patients, camsirubicinfor the treatmentof soft tissue sarcoma, a late-stage preclinical antibody, MNPR-101, for cancers and severe COVID-19 and an early-stage camsirubicin analog, MNPR-202, for various cancers.
About CAN Canaan Inc.
Canaan Inc is a developer of supercomputing chips and the manufacturer of digital blockchain computing equipment and the supplier of the overall scheme for computer software and hardware of digital blockchain. The revenues of the company are derived from the sales of Bitcoin mining machines and related parts and accessories. Geographically, the company derives its maximum revenue from United States.